William F. Bell Jr. - 06 Jun 2023 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role
Director
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
Issuer symbol
PTCT
Transactions as of
06 Jun 2023
Net transactions value
$0
Form type
4
Filing time
07 Jun 2023, 16:07:21 UTC
Next filing
16 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Award $0 +4,000 $0.000000 4,000 06 Jun 2023 Direct F1
transaction PTCT Common Stock Award $0 +2,333 +58% $0.000000 6,333 06 Jun 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTCT Stock Option (Right to Buy) Award $0 +10,000 $0.000000 10,000 06 Jun 2023 Common Stock 10,000 $45.02 Direct F3
transaction PTCT Stock Option (Right to Buy) Award $0 +5,834 $0.000000 5,834 06 Jun 2023 Common Stock 5,834 $45.02 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units granted on June 6, 2023 that vest in three equal installments over three years, commencing on June 6, 2024.
F2 Restricted stock units granted on June 6, 2023 that vest on January 5, 2024.
F3 This option was granted on June 6, 2023 and vests over thirty-six approximately equal monthly installments, commencing on July 6, 2023.
F4 This option was granted on June 6, 2023 and vests over seven approximately equal monthly installments, commencing on July 5, 2023.